baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

FACC AG/ AT00000FACC2 /

06/11/2024 17:35:27	Chg. +0.110	Volume	Bid06/11/2024	Ask17:45:00	Market Capitalization	Dividend Y.	P/E Ratio
6.330EUR	+1.77%	18,158 Turnover: 115,106.297	-Bid Size: -	-Ask Size: -	289.85 mill.EUR	-	31.65

GlobeNewswire 26/08 Milestone® Pharmaceuticals to Present Data on Etripamil at the ESC Congress 2024

GlobeNewswire 14/08 19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. Georg...

GlobeNewswire 13/08 Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Expansion of the Phase 2b MOVE-IT Study of ...

GlobeNewswire 12/08 Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire 08/08 Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and ...

GlobeNewswire 31/07 BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

GlobeNewswire 28/07 Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alz...

GlobeNewswire 18/07 HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in ...

GlobeNewswire 17/07 Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mil...

GlobeNewswire 10/07 Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Desig...

GlobeNewswire 09/07 New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference

GlobeNewswire 08/07 Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weigh...

GlobeNewswire 17/06 Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Init...

GlobeNewswire 12/06 Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspect...

GlobeNewswire 10/06 Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer

GlobeNewswire 05/06 Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

GlobeNewswire 04/06 Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...

GlobeNewswire 17/05 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

GlobeNewswire 17/05 Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biol...

GlobeNewswire 16/05 CVRx Announces Key Senior Leadership Team Hires

GlobeNewswire 15/05 Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium

GlobeNewswire 15/05 HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REV...

GlobeNewswire 07/05 Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...

GlobeNewswire 07/05 Rugby Provides Exploration Update on its Gold-Silver Projects in Santa Cruz Province, Argentina

GlobeNewswire 02/05 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...

FACC AG/ AT00000FACC2 /

If you wish to receive reply to your feedback, please provide your email address.